By GREGORY ZELLER // German venture capitalists have locked and loaded a Stony Brook University spinoff’s next-generation weapon against malignant tumors. Munich-based VC firm TVM Capital Life Science – whose…
By GREGORY ZELLER // A biotech manufacturer with a 23-year history of servicing Stony Brook University researchers and startups is being evicted from the university’s Chemistry Building – and nobody…
By GREGORY ZELLER // Several breakout research projects – and a few familiar faces from the cutting edge – scored funding this week through Stony Brook University’s annual biotechnology awards…
By GREGORY ZELLER // Many have said them, tried their best and fallen short – but the words still have unique and powerful meaning, in medical parlance and beyond. A…